SCHEMBL10187476

SCHEMBL10187476

C=CCC(O)Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRR Q9GZT4 2/20 0.46
PSAT1 Q9Y617 2/20 0.46
PPARG P37231 9/20 0.45
PPARA Q07869 7/20 0.45
MMP2 P08253 1/20 0.42
MMP9 P14780 1/20 0.42
MMP12 P39900 1/20 0.42
MMP13 P45452 1/20 0.42
MMP14 P50281 1/20 0.42
ACP3 P15309 1/20 0.42
FFAR1 O14842 1/20 0.42
MME P08473 3/20 0.40
ABCC4 O15439 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40
PTGS1 P23219 1/20 0.40
HTT P42858 1/20 0.40
CYP2C19 P33261 1/20 0.40
TAAR1 Q96RJ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15184700 0.89 TRPA1 (0.44) SRRTSHRPTGS1CYP2C19TAAR1
SCHEMBL15184715 0.89 TRPA1 (0.44) SRRTSHRPTGS1CYP2C19TAAR1
SCHEMBL2369596 0.89 TRPA1 (0.44) SRRTSHRPTGS1CYP2C19TAAR1
SCHEMBL10187483 0.81 PPARG (0.49) PPARGPPARAMMP12MMP13FFAR1
SCHEMBL18879762 0.79 CA1 (0.45) SRRPSAT1PPARGPPARAMMP2
SCHEMBL1408586 0.79 MME (0.41) SRRPSAT1ACP3MMETAAR1
SCHEMBL24241172 0.78 TRPA1 (0.43) PPARGPPARA
SCHEMBL29033883 0.76 SRR (0.50) SRRPSAT1PPARGPPARAMMP2
SCHEMBL15517655 0.76 SRR (0.50) SRRPSAT1PPARGPPARAMMP2
SCHEMBL29033895 0.76 SRR (0.50) SRRPSAT1PPARGPPARAMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093287-B2 Inhibitors of matrix metalloproteinases UNIVERSITY OF NOTRE DAME DU LAC (US) 2012-01-10 US disclosed
US-20110224275-A1 INHIBITORS OF MATRIX METALLOPROTEINASES NOTRE DAME UNIVERSITY (US) 2011-09-15 US disclosed
US-7928127-B2 Inhibitors of matrix metallaproteinases NOTRE DAME UNIVERSITY (US) 2011-04-19 US disclosed
US-20090005420-A1 Inhibitors of Matrix Metallaproteinases NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005420-A1 Inhibitors of Matrix Metallaproteinases MMP9, MMP1, MMP2 SRR 2320/4885PSAT1 1421/4885PPARG 4192/4885
US-20110224275-A1 INHIBITORS OF MATRIX METALLOPROTEINASES MMP9, MMP1, MMP2 SRR 2387/4885PSAT1 2005/4885PPARG 4218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.